Across TCGA pan-cancer cohorts, IL4R RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated IL4R data layer compared with 5 for mutation status.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher IL4R RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IL4R expression acts as an unfavorable survival marker, although some lineages such as ESCA and UCS show a favorable association.
KIRP, LGG, and LUSC are the cancer types where IL4R RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.